Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $556.4500 (3.06%) ($540.0000 - $557.1500) on Tue. Dec. 15, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.39% (three month average) | RSI | 45 | Latest Price | $556.4500(3.06%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(64%) XLV(51%) XBI(49%) QQQ(42%) IVW(41%) | Factors Impacting REGN price | REGN will decline at least -1.195% in a week (0% probabilities). VIXM(-13%) TLT(-9%) UUP(-6%) SHY(-4%) TIP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.195% (StdDev 2.39%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
1 - 5 Day Possible Target | $548.26(-1.47%) | 5 Day Moving Average | $545.29(2.05%) | 10 Day Moving Average | $547.06(1.72%) | 20 Day Moving Average | $556.4(0.01%) | To recent high | -5.2% | To recent low | 23.2% | Market Cap | $59b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |